Please use this identifier to cite or link to this item: http://sgc.anlis.gob.ar/handle/123456789/387
DC FieldValueLanguage
dc.contributor.authorPérez, Celeste Lujánes
dc.contributor.authorRudoy, Silviaes
dc.date.accessioned2012-11-22T06:21:55Z-
dc.date.available2012-11-22T06:21:55Z-
dc.date.issued2001-09-
dc.identifier.issn1098-6588-
dc.identifier.urihttp://sgc.anlis.gob.ar/handle/123456789/387-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC96184/pdf/cd0501000993.pdf-
dc.identifier.urihttps://cvi.asm.org/content/8/5/993-
dc.descriptionFil: Pérez, Celeste L. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Virología; Argentina.es
dc.descriptionFil: Rudoy, Silvia. Hospital Santojanni. Servicio de Hematología; Argentina.es
dc.description.abstractHuman herpesvirus 8 (HHV-8), or Kaposi's sarcoma-associated herpesvirus, is a gammaherpesvirus first detected in Kaposi's sarcoma tumor cells and subsequently in primary effusion lymphoma (PEL) tumor cells and peripheral blood mononuclear cells from PEL patients. PEL has been recognized as an individual nosologic entity based on its distinctive features and consistent association with HHV-8 infection. PEL is an unusual form of body cavity-based B-cell lymphoma (BCBL). It occurs predominantly in human immunodeficiency virus (HIV)-positive patients but occasionally also in elderly HIV-negative patients. We describe a case of PEL, with ascites, bilateral pleural effusions, and a small axillary lymphadenopathy, in a 72-year-old HIV-negative man. PCR performed on a lymph node specimen and in liquid effusion was positive for HHV-8 and negative for Epstein-Barr virus. The immunophenotype of the neoplastic cells was B CD19+ CD20+ CD22+ with coexpression of CD10 and CD23 and with clonal kappa light chain rearrangement. The patient was treated with Rituximab, a chimeric (human-mouse) anti-CD20 monoclonal antibody. Thirteen months later, the patient continued in clinical remission. This is the first report of an HHV-8-associated BCBL in an HIV-negative patient in Argentina.es
dc.formatapplication/pdfES
dc.language.isoenes
dc.relation.ispartofClinical and diagnostic laboratory immunologyes
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsOpen Access-
dc.rightsCreative Commons Attribution 4.0 International License-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceClinical and Diagnostic Laboratory Immunology, 2001, 8(5), 993-996.en_US
dc.subjectAnticuerpos Monoclonaleses
dc.subjectAntígenos CD20es
dc.subjectHerpesvirus Humano 8es
dc.subjectLinfoma de Células Bes
dc.subjectSeronegatividad para VIHes
dc.titleAnti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patientes
dc.typeArtículoes
anlis.essnrd1es
item.openairetypeArtículo-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
crisitem.author.deptMaestría en Microbiología Molecular UNSM-ANLIS-
crisitem.author.parentorgCentro Nacional Red de Laboratorios (CNRL)-
Appears in Collections:snrd
Publicaciones INEI
Files in This Item:
File Description SizeFormat
ClinicalandDiagnosticLaboratoryImmunology,2001,8(5),993-996..pdfPDF174.04 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

64
checked on Mar 28, 2024

Download(s)

66
checked on Mar 28, 2024

Google ScholarTM

Check


This item is licensed under a Creative Commons License Creative Commons